Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methylprednisolone sodium succinate (substance) |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone adverse reaction |
Causative agent (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone measurement (procedure) |
Has measured component |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone measurement (procedure) |
Component |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone sodium succinate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to methylprednisolone |
Causative agent (attribute) |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate+lignocaine hydrochloride 80/20mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acétate de méthylprednisolone et chlorhydrate de lidocaïne 40/10 mg/1 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
méthylprednisolone 50 mg/mL, flacon de 10 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 1g/20mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 500mg injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
méthylprednisolone 1 g, fiole de poudre pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
méthylprednisolone 40 mg, fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
méthylprednisolone 125 mg, fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
méthylprednisolone 500 mg, fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
méthylprednisolone 1 g, fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
méthylprednisolone 2 g, fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone- and neomycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing methylprednisolone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral methylprednisolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone sodium succinate 40mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 125mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 1g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 500mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 2g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate 500g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 40mg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 125mg/2mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 40mg/mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 125mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium su 125mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intramuscular injection of methylprednisolone |
Direct substance |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing methylprednisolone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intramuscular injection of methylprednisolone |
Direct substance |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intramuscular injection of methylprednisolone |
Direct substance |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone pulse therapy |
Direct substance |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to methylprednisolone |
Causative agent (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to methylprednisolone |
Causative agent (attribute) |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Methylprednisolone aceponate (substance) |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 16 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone hemisuccinate (substance) |
Is a |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone hemisuccinate (substance) |
Is modification of (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone sodium succinate |
Is modification of (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone aceponate (substance) |
Is modification of (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate |
Is modification of (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone 100 mg oral tablet |
Has precise active ingredient |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 2 mg oral tablet |
Has precise active ingredient |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 4 mg oral tablet |
Has precise active ingredient |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone 16 mg oral tablet |
Has precise active ingredient |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine- and methylprednisolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone and neomycin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only methylprednisolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only methylprednisolone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lidocaine and methylprednisolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
méthylprednisolone 1 g, fiole de poudre pour injection |
Has basis of strength substance (attribute) |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
méthylprednisolone 1 g, fiole de poudre pour injection |
Has precise active ingredient |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 125 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
False |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 40 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 125 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone (as methylprednisolone sodium succinate) 500 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Methylprednisolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |